SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001723128-19-000094
Filing Date
2019-05-13
Accepted
2019-05-13 17:27:15
Documents
1
Period of Report
2019-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_155778282066089.html 4  
1 FORM 4 wf-form4_155778282066089.xml 4 3678
  Complete submission text file 0001723128-19-000094.txt   5013
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
Todisco Joseph (Reporting) CIK: 0001774807 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 19819553